Plus Therapeutics Cash Flow Statement (2010-2025) | PSTV

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-2.72M-2.80M-3.73M-4.12M-5.30M-5.25M-5.61M-4.77M-1.48M-3.22M-3.81M-3.26M-3.66M-3.78M-3.90M-4.08M-1.51M-4.42M-5.71M
Share-based Compensation (Quarter)
0.11M0.18M0.17M0.13M0.13M0.14M0.14M0.15M0.14M0.15M0.15M0.12M0.13M0.15M0.15M0.53M0.71M
Gains from Sales and Divestitures (Quarter)
0.22M
Gains from Investment Securities (Quarter)
0.01M0.00M-0.00M1.17M17.0017.001.18M2.37M37.000.13M0.01M0.16M0.34M0.60M1.27M0.71M11.27M0.13M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
149.00343.001.09M1.10M0.54M0.59M0.67M0.76M1.36M0.00M0.01M0.01M0.00M0.11M0.20M0.00M1.68M
Cash from Operations (Quarter)
-3.01M-3.88M-2.64M-4.22M-2.23M-5.79M-2.78M-2.40M-1.88M-4.51M-1.15M-3.68M-1.21M-6.17M-5.80M-2.53M-6.28M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.03M0.01M0.03M0.03M0.03M0.03M0.03M0.03M0.03M-0.01M0.07M0.01M0.04M-0.01M-0.00M-0.01M
Amortization of Deferred Charges (Quarter)
0.15M0.12M0.10M0.09M0.08M0.07M0.05M0.04M0.03M0.02M0.00M
Depreciation & Amortization (CF) (Quarter)
0.09M0.15M0.15M0.16M0.16M0.16M0.16M0.16M0.15M0.15M0.17M0.20M0.35M0.15M0.08M0.08M0.14M
Change in Working Capital
Change in Receivables (Quarter)
Change in Inventory (Quarter)
Change in Accured Expenses (Quarter)
-0.46M-0.65M2.18M0.43M4.50M-3.64M0.05M-0.47M0.38M-0.04M0.40M0.97M3.38M-2.42M-2.76M-1.13M0.69M
Other Working Capital Changes (Quarter)
0.17M-0.46M-0.07M0.42M-0.03M-0.03M-0.03M-0.03M-0.03M-0.15M-0.18M0.24M-0.12M-0.07M0.03M-0.01M-0.01M
Investing Activities
Capital Expenditures (Quarter)
0.08M0.21M0.14M0.03M0.13M0.10M0.01M0.01M0.04M0.04M0.08M0.01M0.01M0.00M0.01M0.03M0.03M
Sales of Property, Plant and Equipment (Quarter)
-0.05M0.03M
Change in Intangibles (Quarter)
0.12M
Cash from Investing Activities (Quarter)
-0.08M-0.58M-0.14M-0.03M-0.01M-0.10M-0.01M-0.01M-0.04M-0.36M-3.80M-0.01M0.06M3.56M-4.63M1.30M-1.08M
Financing Activities
Other financing activities (Quarter)
0.77M2.03M
Cash from Financing Activities (Quarter)
9.19M7.29M-0.37M6.43M0.10M0.49M0.96M2.52M-0.53M-0.78M6.96M12.40M2.80M12.31M2.80M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
6.10M2.84M-3.15M2.18M-2.15M-5.40M-1.83M0.11M-2.45M-5.65M2.01M-3.69M-1.15M9.79M-7.63M11.06M-4.53M
Free Cash Flow (Quarter)
-3.09M-4.09M-2.78M-4.25M-2.36M-5.89M-2.79M-2.41M-1.92M-4.55M-1.23M-3.69M-1.22M-6.17M-5.80M-2.56M-6.30M
Net Cash Flow (Quarter)
6.10M2.84M-3.15M2.18M-2.15M-5.40M-1.83M0.11M-2.45M-5.65M2.01M-3.69M-1.15M9.79M-7.63M11.07M-4.55M